Prosecution Insights
Last updated: August 17, 2026

Examiner: GABEL, GAILENE

Tech Center 1700 • Art Units: 1641 1677 1678 1681 1759

This examiner grants 76% of resolved cases

Performance Statistics

75.6%
Allow Rate
+10.6% vs TC avg
949
Total Applications
+44.9%
Interview Lift
1122
Avg Prosecution Days
Based on 930 resolved cases, 2023–2026

Rejection Statute Breakdown

5.8%
§101 Eligibility
17.9%
§102 Novelty
28.0%
§103 Obviousness
34.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18684221 BIOMARKER COMPOSITIONS AND METHODS OF USE THEREOF Non-Final OA Siemens Healthcare Diagnostics Inc.
17799164 MONITORING VIABILITY OF ORGANS FOR TRANSPLANTATION Non-Final OA The General Hospital Corporation
18413506 DELAY PROCESS TO PROVIDE TIMED CHEMISTRY TO LATERAL-FLOW IMMUNOASSAYS Non-Final OA The Government of the United States of America, as represented by the Secretary of the Navy
18355536 MAGNETIC-FIELD BIOSENSOR MEASURING A DIFFERENTIAL SIGNAL FROM AT LEAST TWO MAGNETIC-FIELD SENSING ELEMENTS Non-Final OA Allegro MicroSystems, LLC
18362678 IDENTIFICATION AND ISOLATION OF HUMAN CORNEAL ENDOTHELIAL CELLS (HCECS) Non-Final OA EMMETROPE OPHTHALMICS LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month